Company Profiles

driven by the PitchBook Platform

Complexa

Description

Developer of therapies for the treatment of inflammatory and metabolic diseases. The company's lead program targets Type 2 diabetes with the potential to expand indications into the treatment of multiple aspects of dysmetabolic syndrome. The company's proprietary technology involves the synthesis and therapeutic applications of endogenous nitro-fatty acids (NFAs) and additional structure/function-related mediators that are designed to treat various diseases.

2008

Founded

PRIVATE

Status

Later Stage VC

Latest Deal Type

$5.95M

Latest Deal Amount

$24.5M

Total Amount Raised

7

Investors

Description

Developer of therapies for the treatment of inflammatory and metabolic diseases. The company's lead program targets Type 2 diabetes with the potential to expand indications into the treatment of multiple aspects of dysmetabolic syndrome. The company's proprietary technology involves the synthesis and therapeutic applications of endogenous nitro-fatty acids (NFAs) and additional structure/function-related mediators that are designed to treat various diseases.

Website:

www.complexarx.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

2425 Sidney Street Pittsburgh, PA 15203United States +1 (412) 727-8727
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Complexa's full profile, request a free trial.

    Complexa Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Complexa Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Complexa Investors (7)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BlueTree Allied AngelsVenture CapitalMinority000 0000000 0000
    Individual InvestorAngel (individual)Minority000 0000000 0000
    Innovation WorksVenture CapitalMinority000 0000000 0000
    JAFCOVenture CapitalMinority000 0000000 0000
    Pittsburgh Life Sciences GreenhouseVenture CapitalMinority000 0000000 0000
    BlueTree Allied Angels Venture Capital
    Individual Investor Angel (individual)
    Innovation Works Venture Capital
    JAFCO Venture Capital
    Pittsburgh Life Sciences Greenhouse Venture Capital

    Complexa Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Joshua TarnoffDirector, President & Chief Executive Officer
    Federica O'BrienChief Financial Officer
    Arthur FinnelChief Financial Officer, Finance
    Bruce FreemanCo-Founder
    Meg Tarpey MDCo-Founder
    Joshua Tarnoff Director, President & Chief Executive Officer
    Federica O'Brien Chief Financial Officer
    Arthur Finnel Chief Financial Officer, Finance
    Bruce Freeman Co-Founder
    Meg Tarpey MD Co-Founder

    Complexa Board Members (9)

    NameRepresentingRoleSinceContact
    Info
    Carter Meyer JDSelfBoard Member000 0000
    Harold Safferstein Ph.DPittsburgh Life Sciences GreenhouseExecutive-in-Residence000 0000
    Hironori HozojiJAFCOInvestment Officer000 0000
    I. Morris IIISelfBoard Member000 0000
    Joseph Reiser Ph.DSelfChairman000 0000
    Carter Meyer JD Board Member Self
    Harold Safferstein Ph.D Executive-in-Residence Pittsburgh Life Sciences Greenhouse
    Hironori Hozoji Investment Officer JAFCO
    I. Morris III Board Member Self
    Joseph Reiser Ph.D Chairman Self
    Request full access to PitchBook